The stock of Mediclinic International PLC (LON:MDC) reached all time low today, Nov, 11 and still has GBX 700.41 target or 8.00% below today’s GBX 761.31 share price. This indicates more downside for the GBX 4.73B company. This technical setup was reported by Barchart.com. If the GBX 700.41 PT is reached, the company will be worth GBX 378.40 million less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. The stock decreased 1.89% or GBX 14.69 on November 11, hitting GBX 761.31. About 4.18 million shares traded hands or 205.11% up from the average. Mediclinic International PLC (LON:MDC) has declined 19.26% since April 15, 2016 and is downtrending. It has underperformed by 25.40% the S&P500.
Mediclinic International PLC (LON:MDC) Ratings Coverage
Out of 10 analysts covering Mediclinic International (LON:MDC), 3 rate it a “Buy”, 1 “Sell”, while 6 “Hold”. This means 30% are positive. Mediclinic International has been the topic of 16 analyst reports since February 18, 2016 according to StockzIntelligence Inc. The rating was maintained by Jefferies on Wednesday, September 28 with “Hold”. The stock of Mediclinic International PLC (LON:MDC) earned “Buy” rating by Investec on Monday, March 14. Credit Suisse maintained the stock with “Outperform” rating in Friday, November 11 report. The stock of Mediclinic International PLC (LON:MDC) has “Buy” rating given on Monday, May 9 by Investec. Citigroup maintained Mediclinic International PLC (LON:MDC) on Tuesday, May 24 with “Neutral” rating. The firm has “Reduce” rating given on Friday, November 11 by HSBC. Jefferies maintained Mediclinic International PLC (LON:MDC) on Thursday, September 22 with “Hold” rating. The company was maintained on Tuesday, July 26 by Jefferies. The rating was maintained by JP Morgan on Tuesday, August 23 with “Neutral”. Citigroup upgraded the shares of MDC in a report on Tuesday, June 28 to “Buy” rating.
More news for Mediclinic International PLC (LON:MDC) were recently published by: Fool.Co.Uk, which released: “Paddy Power Betfair PLC Ord Eur0.09 & Mediclinic International PLC Set To …” on February 29, 2016. Fool.Co.Uk‘s article titled: “Are Mediclinic International plc, AstraZeneca plc and Smith & Nephew plc the …” and published on May 25, 2016 is yet another important article.
Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The company has a market cap of 4.73 billion GBP. The Firm operates as an international private healthcare provider. It has a 18.12 P/E ratio. The Company’s divisions include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.